المؤلفون: Ernst-Jan M. Speel, Nils A. 't Hart, B. E. van den Borne, E. Van Der Heijden, Monika G. Looijen-Salamon, S. Riemersma, Lizza E.L. Hendriks, A. J. van der Wekken, Harry J.M. Groen, Ed Schuuring, Wim Timens, R. Pelgrim, A. Van Den Berg, Thijo J N Hiltermann, A.J. de Langen, N Werner, J. Staal-van den Brekel, Anne-Marie C. Dingemans, M. F. Mastik

المساهمون: Stem Cell Aging Leukemia and Lymphoma (SALL), Translational Immunology Groningen (TRIGR), Groningen Research Institute for Asthma and COPD (GRIAC), Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON), Guided Treatment in Optimal Selected Cancer Patients (GUTS), CCA - Cancer Treatment and quality of life, Pulmonary medicine, Pulmonologie, Promovendi ODB, MUMC+: MA Med Staf Spec Longziekten (9), RS: GROW - R2 - Basic and Translational Cancer Biology, Pathologie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Epidemiologie

المصدر: Clinical Cancer Research, 23(15), 4251-4258. AMER ASSOC CANCER RESEARCH
Europe PubMed Central
Clinical Cancer Research, 23(15), 4251-4258. American Association for Cancer Research Inc.
Clinical Cancer Research, 23, 4251-4258
Clinical Cancer Research, 23, 15, pp. 4251-4258
Van Der Wekken, A J, Pelgrim, R, T Hart, N, Werner, N, Mastik, M F, Hendriks, L, Van Der Heijden, E H F M, Looijen-Salamon, M, De Langen, A J, Staal-Van Den Brekel, J, Riemersma, S, Van Den Borne, B E, Speel, E J M, Dingemans, A M C, Hiltermann, T J N, Van Den Berg, A, Timens, W, Schuuring, E & Groen, H J M 2017, ' Dichotomous ALK-IHC is a better predictor for ALK inhibition outcome than traditional ALK-FISH in advanced non–small cell lung cancer ', Clinical Cancer Research, vol. 23, no. 15, pp. 4251-4258 . https://doi.org/10.1158/1078-0432.CCR-16-1631Test

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Pathology, Pyridines, FUSION, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, hemic and lymphatic diseases, Anaplastic lymphoma kinase, Anaplastic Lymphoma Kinase, GENE REARRANGEMENT, In Situ Hybridization, Fluorescence, CRIZOTINIB THERAPY, medicine.diagnostic_test, Middle Aged, Prognosis, Gene Expression Regulation, Neoplastic, CARCINOMAS, 030220 oncology & carcinogenesis, Adenocarcinoma, Female, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], medicine.drug, Adult, medicine.medical_specialty, Biopsy, Fine-Needle, Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9], Disease-Free Survival, 03 medical and health sciences, Crizotinib, Internal medicine, Biopsy, Biomarkers, Tumor, medicine, Carcinoma, Humans, IMMUNOHISTOCHEMISTRY, Lung cancer, Aged, IDENTIFICATION, business.industry, Receptor Protein-Tyrosine Kinases, Cancer, ADENOCARCINOMA, Gene rearrangement, IN-SITU HYBRIDIZATION, medicine.disease, COPY NUMBER, 030104 developmental biology, Pyrazoles, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::294301d2488887f96efb73185cf8e257Test
https://doi.org/10.1158/1078-0432.ccr-16-1631Test

المؤلفون: Tineke W.H. Meijer, Johan Bussink, Johannes H.A.M. Kaanders, Erik H.F.M. van der Heijden, Monika G. Looijen-Salamon, Wim J.G. Oyen, Eric P. Visser, Paul N. Span, Miep A. van der Drift, Lioe-Fee de Geus-Oei, Olga C.J. Schuurbiers

المصدر: Journal of Thoracic Oncology, 9, 10, pp. 1485-93
Journal of Thoracic Oncology, 9, 1485-93

مصطلحات موضوعية: Male, Pathology, Lung Neoplasms, Cell, Muscle Proteins, Hypoxia-related markers, 030218 nuclear medicine & medical imaging, 0302 clinical medicine, Carbonic Anhydrases, Glucose Transporter Type 1, 18-Fluoro-2-deoxyglucose positron emission tomography, biology, Symporters, Middle Aged, Prognosis, Cell Hypoxia, 3. Good health, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], medicine.anatomical_structure, Real-time polymerase chain reaction, Monocarboxylate transporter 1, Oncology, Tumor microenvironment, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Adenocarcinoma, Female, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9], Pulmonary and Respiratory Medicine, Monocarboxylic Acid Transporters, medicine.medical_specialty, Adenocarcinoma of Lung, Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9], Disease-Free Survival, 03 medical and health sciences, Antigens, Neoplasm, Fluorodeoxyglucose F18, medicine, Carcinoma, Humans, Carbonic Anhydrase IX, Aged, Neoplasm Staging, business.industry, Non–small-cell lung cancer, Other Research Radboud Institute for Health Sciences [Radboudumc 0], Histology, medicine.disease, Tumor glucose metabolism, Glucose, Positron-Emission Tomography, biology.protein, GLUT1, Radiopharmaceuticals, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd5eed41c598b0564cec9ac0cca5119dTest
https://doi.org/10.1097/JTO.0000000000000286Test